🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 6 week study to assess the effect of BI 671800 in patients with a...
Status
Completed
Location
1268.16.01004 Boehringer Ingelheim Investigational Site
Start Date
2010-04-20
Trial ID
NCT01103349
Treatments Being Tested
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
Beta-endorphins, which are naturally occurring narcotic substances, have be...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2011-06
Trial ID
NCT01378520
Treatments Being Tested
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
The study purpose is to evaluate the effect of QAB149 * NVA237 vs. QAB149 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01699685
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-28
Trial ID
NCT02242266
The primary objective of this study is to investigate the effect of 4-week ...
Status
Withdrawn
Location
1219.4.01001 Boehringer Ingelheim Investigational Site
Start Date
2008-08
Trial ID
NCT00726479
Treatments Being Tested
The purpose is to Evaluate the Efficacy, Safety, and Tolerability of 3 Diff...
Status
Completed
Location
Research Site
Start Date
2012-11
Trial ID
NCT01704495
This study will be the first administration of CCI15106 capsules for inhala...
Status
Terminated
Location
GSK Investigational Site
Start Date
2016-02-10
Trial ID
NCT03243760
Treatments Being Tested